A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

January 17, 2023

Study Completion Date

February 15, 2023

Conditions
Advanced Solid Tumor
Interventions
DRUG

HBM4003

Intravenous (IV) administration

Trial Locations (17)

2109

Macquarie University, 2 Technology Place, Macquarie

2217

St. George Private Hospital, 1 South Street, Kogarah

3004

The Alfred Hospital, Commercial Road, Melbourne

3168

Monash Health, Monash Medical Centre, 246 Clayton Road, Clayton

100034

Peking University First Hospital, Chemotherapy Department, No. 15 cheniandian Hutong, Annei Street, Dongcheng District, Beijing

199921

Cancer Hospital Chinese Academy of Medical Sciences, Oncology Department, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing

221000

Xuzhou Central Hospital, Oncology Department, No. 199 Jiefang South Road, Quanshan District, Xuzhou

264000

Yantai Yuhuangding Hospital, Urology Department, 8th Floor, No. 20 Donglu Road, Zhifu District, Yantai

300060

Tianjin Medical University Cancer Institute and Hospital, Biotherapeutic Department, 17 / F, Block C, West Huan-Hu Rd., Ti Yuan Bei, Hexi District, Tianjin

310011

Zhejiang Cancer Hospital, Department of Head and Neck Medicine for Rare Diseases, No. 1, Banshan Road, Gongshu District, Hangzhou

Zhenjiang Cancer Hospital, Department of Interventional Therapy, No. 1, Banshan Road, Gongshu District, Hangzhou

410006

Hunan Cancer Hospital, Intervention Division, 83 Tongzipo Road, Yuelu District, Changsha

Hunan Cancer Hospital, Urology Department, 83 Tongzipo Road, Yuelu District, Changsha

430022

Union Hospital affiliated to Tongji Medical College of HUST, Oncology Department, No. 1277 Jiefang Dadao, Wuhan

450000

Henan Cancer Hospital, Oncology Department, No. 127 Dongming Road, Jinshui District, Zhengzhou

644000

The Second People's Hospital of Yibin, Oncology Department, No. 268 South Bank Nanguang Road, Xuzhou District, Yibin

Unknown

Queen Mary Hospital, Department of Medicine, 102 Pok Fu Lam Road, Hong Kong

Sponsors
All Listed Sponsors
lead

Harbour BioMed US, Inc.

INDUSTRY